The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure
Abstract Background Management of the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by aortic disorders is the two strategies of surgical intervention and medical treatment based on the patient’s age and comorbidities. Case presentation An 81-year-old woman with a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-01-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-024-03750-0 |
| _version_ | 1797275981483868160 |
|---|---|
| author | Hiroki Okamoto Tomoya Ozawa Tomoaki Suzuki Yoshihisa Nakagawa |
| author_facet | Hiroki Okamoto Tomoya Ozawa Tomoaki Suzuki Yoshihisa Nakagawa |
| author_sort | Hiroki Okamoto |
| collection | DOAJ |
| description | Abstract Background Management of the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by aortic disorders is the two strategies of surgical intervention and medical treatment based on the patient’s age and comorbidities. Case presentation An 81-year-old woman with a history of two previous aortic surgeries and chronic heart and renal failure was admitted for uncontrollable subcutaneous hemorrhage. The hemorrhage was caused by the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by periprosthetic graft hematoma after aortic replacement for Stanford type A aortic dissection. Open thoracic hemostasis temporarily controlled the subcutaneous hemorrhage, but she was readmitted for the recurrence seven months after discharge. On the second admission, the combination of anticoagulant and antifibrinolytic agents was successful. Conclusion Management of the enhanced-fibrinolytic type of DIC caused by aortic disorders is important of a successful combination of surgical and medical therapy tailored the patient’s condition. |
| first_indexed | 2024-03-07T15:20:54Z |
| format | Article |
| id | doaj.art-5a629ca7acc44fa9858b81af9fff0688 |
| institution | Directory Open Access Journal |
| issn | 1471-2261 |
| language | English |
| last_indexed | 2024-03-07T15:20:54Z |
| publishDate | 2024-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cardiovascular Disorders |
| spelling | doaj.art-5a629ca7acc44fa9858b81af9fff06882024-03-05T17:37:23ZengBMCBMC Cardiovascular Disorders1471-22612024-01-012411610.1186/s12872-024-03750-0The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failureHiroki Okamoto0Tomoya Ozawa1Tomoaki Suzuki2Yoshihisa Nakagawa3Department of Internal Medicine, Division of Cardiovascular Medicine, Shiga University of Medical ScienceDepartment of Internal Medicine, Division of Cardiovascular Medicine, Shiga University of Medical ScienceDepartment of Surgery, Division of Cardiovascular Surgery, Shiga University of Medical ScienceDepartment of Internal Medicine, Division of Cardiovascular Medicine, Shiga University of Medical ScienceAbstract Background Management of the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by aortic disorders is the two strategies of surgical intervention and medical treatment based on the patient’s age and comorbidities. Case presentation An 81-year-old woman with a history of two previous aortic surgeries and chronic heart and renal failure was admitted for uncontrollable subcutaneous hemorrhage. The hemorrhage was caused by the enhanced-fibrinolytic type of disseminated intravascular coagulation (DIC) caused by periprosthetic graft hematoma after aortic replacement for Stanford type A aortic dissection. Open thoracic hemostasis temporarily controlled the subcutaneous hemorrhage, but she was readmitted for the recurrence seven months after discharge. On the second admission, the combination of anticoagulant and antifibrinolytic agents was successful. Conclusion Management of the enhanced-fibrinolytic type of DIC caused by aortic disorders is important of a successful combination of surgical and medical therapy tailored the patient’s condition.https://doi.org/10.1186/s12872-024-03750-0Disseminated intravascular coagulationAortic diseaseHematomaAnticoagulant therapyAntifibrinolytic therapy |
| spellingShingle | Hiroki Okamoto Tomoya Ozawa Tomoaki Suzuki Yoshihisa Nakagawa The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure BMC Cardiovascular Disorders Disseminated intravascular coagulation Aortic disease Hematoma Anticoagulant therapy Antifibrinolytic therapy |
| title | The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure |
| title_full | The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure |
| title_fullStr | The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure |
| title_full_unstemmed | The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure |
| title_short | The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure |
| title_sort | two therapeutic strategies of surgical intervention and medical management in a patient with enhanced fibrinolytic type of disseminated intravascular coagulation after aortic replacement for stanford type a aortic dissection with chronic heart and renal failure |
| topic | Disseminated intravascular coagulation Aortic disease Hematoma Anticoagulant therapy Antifibrinolytic therapy |
| url | https://doi.org/10.1186/s12872-024-03750-0 |
| work_keys_str_mv | AT hirokiokamoto thetwotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure AT tomoyaozawa thetwotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure AT tomoakisuzuki thetwotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure AT yoshihisanakagawa thetwotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure AT hirokiokamoto twotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure AT tomoyaozawa twotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure AT tomoakisuzuki twotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure AT yoshihisanakagawa twotherapeuticstrategiesofsurgicalinterventionandmedicalmanagementinapatientwithenhancedfibrinolytictypeofdisseminatedintravascularcoagulationafteraorticreplacementforstanfordtypeaaorticdissectionwithchronicheartandrenalfailure |